****IMMEDIATE ASSOCIATE DIRECTOR CLINICAL OPERATIONS OPPORTUNITY WITH GROWING PHARMA Summary: The Associate Director... preferred) 6+ years of clinical, drug, or biologics development in the pharmaceutical or biotech industry Additional...
650 clients ranging from innovative biotech start-ups to established pharmaceutical companies. Our products, services.... Job Description The EVERSANA/Millicent Pharma Specialty Pharmaceutical Representative will be responsible for selling Intrarosa & Femring...
650 clients ranging from innovative biotech start-ups to established pharmaceutical companies. Our products, services.... Job Description The EVERSANA/Millicent Pharma Specialty Pharmaceutical Representative will be responsible for selling Intrarosa & Femring...
and forecasting capabilities, both within and outside of pharma, which can be applied within the organization Required Experience... / Biotech / Healthcare analytics or secondary data analysis and forecasting 5+ years of pharmaceutical industry experience...
650 clients ranging from innovative biotech start-ups to established pharmaceutical companies. Our products, services.... Job Description The EVERSANA/Millicent Pharma Specialty Pharmaceutical Representative will be responsible for selling Intrarosa & Femring...
responsible experience as a Quality Assurance Specialist or closely-related role in pharma/biotech setting. Experience... to biotech and pharmaceuticals. Working with the following software: MasterControl, LIMs, Trackwise, LabX, Blue Mountain...
For Current Kite Pharma Employees and Contractors: Please log onto... specifications. Experience in a biotech or pharmaceutical company with experience with GMP facility operation. Exposure...
, biotech, and medical device clients - delivering unparalleled levels of strategic service, creative and technological... with a main focus on digital media and real-time buying platforms Pharma experience strongly preferred You can detect and translate...
's Degree with 5 years of demonstrated and relevant experience in pharma/biotech project management and cross functional team... of pharma quality and regulatory framework. Demonstrated in-depth experience managing multiple clinical studies in parallel...
with a strong background in engineering, particularly in process and mechanical piping for medical device, biotech, pharma, and life sciences... Management: Manage and coordinate engineering projects within the Medical device, biotech, pharma, and Life Sciences sectors...
Stocks to Buy : Indian Hotels Company , CDSL , Welspun Enterprises , Sterling and Wilson Renewable Energy (SWSOLAR) are the four stock picks by Yes Securities for the month of May'2024. They anticipate up to 30% upside for these stocks Continue Reading »
Energy Mission Machineries IPO opens for subscription on May 9 and closes on May 13, with a price band of ₹131-138 per share. The firm provides metal fabrication solutions to various sectors using CNC, NC, and traditional metal forming equipment. Continue Reading »
FPIs sell ₹8,671 crore of Indian equities in April, concentrating on IT, financials, and FMCG shares. They continue buying in Telecom and Capital Goods sectors. Overall, FPI equity portfolio in India rose to ₹66.27 lakh crore by April 30. Continue Reading »
Global brokerage Citi Research sees potential for nearly 100% upside in Vodafone Idea stock, setting a target price of ₹25. Key assumptions include higher tariff hikes, subscriber additions, decline in AGR debt, and improved net debt/EBITDA ratio by FY28E. Continue Reading »
Hitachi Energy India's stock soared by 1235% from its 2020 low, with impressive annual returns. The company, a key player in the energy sector, is strategically positioned to benefit from India's energy transition. Goldman Sachs foresees significant growth potential for Hitachi Energy in India. Continue Reading »
Paytm share price is rising after the newsbreak of Epay, which agreed to leverage its license to assist Paytm in onboarding new customers, say experts Continue Reading »
Sula Vineyards, India's largest wine producer, saw a 5.60% drop in shares to ₹511.60 apiece amid negative investor response to Q4FY24 earnings. The company's profit for the March quarter was affected by the increase in raw material prices. The PAT declined by nearly 5% YoY to ₹13.55 crore in Q4. Continue Reading »
Positive management commentary on the FY25 demand outlook brightens prospects for the domestic FMCG sector. Experts optimistic about rural demand revival and potential agri-sector growth, recommending stocks like Dabur, ITC, and Godrej Consumer. Continue Reading »